Quick Answer
SI-BONE, Inc. reported Total Revenue of $200.93 million for fiscal year 2025.
SI-BONE, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $200.93M +20.2% |
$167.18M +20.4% |
$138.89M +30.5% |
$106.41M +18.0% |
$90.15M +22.8% |
$73.39M +9.0% |
| Revenue (ASC 606) | $200.93M +20.2% |
$167.18M +20.4% |
$138.89M +30.5% |
$106.41M +18.0% |
$90.15M +22.8% |
$73.39M +9.0% |
| Net Income | -$18.90M +38.8% |
-$30.91M +28.7% |
-$43.34M +29.3% |
-$61.26M -8.3% |
-$56.57M -29.5% |
-$43.70M -13.8% |
| Diluted EPS | -$0.44 +41.3% |
-$0.75 +33.6% |
-$1.13 +36.9% |
-$1.79 -4.7% |
-$1.71 -14.0% |
-$1.50 |
| Total Assets | $238.56M +3.5% |
$230.44M +0.0% |
$230.43M +46.3% |
$157.55M -17.3% |
$190.51M -14.6% |
$223.14M +90.7% |
| Cash and Equivalents | $42.24M +20.9% |
$34.95M +5.0% |
$33.27M +60.6% |
$20.72M -67.3% |
$63.42M +18.4% |
$53.58M +413.5% |
| Long-Term Debt | $35.57M +0.3% |
$35.45M -1.7% |
$36.06M +2.5% |
$35.17M +0.6% |
$34.97M -11.4% |
$39.45M +13.2% |
| Stockholders Equity | $177.53M +6.3% |
$166.96M -1.4% |
$169.38M +72.3% |
$98.30M -26.9% |
$134.42M -20.6% |
$169.36M +168.8% |
| R&D Expense | $17.45M +5.4% |
$16.56M +10.2% |
$15.03M +10.3% |
$13.63M +9.5% |
$12.44M +31.5% |
$9.46M +29.9% |
| Operating Income | -$22.33M +36.6% |
-$35.25M +24.9% |
-$46.93M +21.3% |
-$59.61M -15.4% |
-$51.67M -34.0% |
-$38.57M -7.1% |
| Gross Profit | $159.88M +21.0% |
$132.12M +20.7% |
$109.42M +20.6% |
$90.70M +13.8% |
$79.72M +23.6% |
$64.48M +6.6% |
| Shares Outstanding | 43.65M +3.7% |
42.09M +3.4% |
40.69M +17.2% |
34.73M +3.1% |
33.67M +3.3% |
32.58M +29.5% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $48.66M | +20.6% | +0.1% |
| Revenue (ASC 606) | September 30, 2025 | $48.66M | +20.6% | +0.1% |
| Net Income | September 30, 2025 | -$4.57M | +30.6% | +25.8% |
| Diluted EPS | September 30, 2025 | -$0.11 | +31.2% | +21.4% |
| Total Assets | September 30, 2025 | $234.27M | +3.2% | +1.5% |
| Cash and Equivalents | September 30, 2025 | $26.49M | -12.4% | -22.4% |
| Long-Term Debt | September 30, 2025 | $35.54M | -1.8% | +0.1% |
| Stockholders Equity | September 30, 2025 | $172.13M | +4.3% | +1.0% |
| R&D Expense | September 30, 2025 | $4.24M | +6.2% | -1.6% |
| Operating Income | September 30, 2025 | -$5.38M | +29.5% | +23.1% |
| Gross Profit | September 30, 2025 | $38.85M | +21.8% | +0.1% |
| Shares Outstanding | September 30, 2025 | 43.27M | +3.5% | +0.6% |
- SI-BONE, Inc. reported Total Revenue of $200.93 million for fiscal year 2025.
- SI-BONE, Inc. showed an increase of +20.2% in Total Revenue compared to the prior fiscal year.
- SI-BONE, Inc. reported Revenue (ASC 606) of $200.93 million for fiscal year 2025.
- SI-BONE, Inc. showed an increase of +20.2% in Revenue (ASC 606) compared to the prior fiscal year.
- SI-BONE, Inc. reported Net Income of -$18.90 million for fiscal year 2025.
- SI-BONE, Inc. showed an increase of +38.8% in Net Income compared to the prior fiscal year.
- SI-BONE, Inc. reported Diluted EPS of $0.44 per share (loss) for fiscal year 2025.
- SI-BONE, Inc. showed an increase of +41.3% in Diluted EPS compared to the prior fiscal year.
- SI-BONE, Inc. reported Total Assets of $238.56 million for fiscal year 2025.
- SI-BONE, Inc. showed an increase of +3.5% in Total Assets compared to the prior fiscal year.
- SI-BONE, Inc. reported Cash and Equivalents of $42.24 million for fiscal year 2025.
- SI-BONE, Inc. showed an increase of +20.9% in Cash and Equivalents compared to the prior fiscal year.
- SI-BONE, Inc. reported Long-Term Debt of $35.57 million for fiscal year 2025.
- SI-BONE, Inc. showed an increase of +0.3% in Long-Term Debt compared to the prior fiscal year.
- SI-BONE, Inc. reported Stockholders Equity of $177.53 million for fiscal year 2025.
- SI-BONE, Inc. showed an increase of +6.3% in Stockholders Equity compared to the prior fiscal year.
- SI-BONE, Inc. reported R&D Expense of $17.45 million for fiscal year 2025.
- SI-BONE, Inc. showed an increase of +5.4% in R&D Expense compared to the prior fiscal year.
- SI-BONE, Inc. reported Operating Income of -$22.33 million for fiscal year 2025.
- SI-BONE, Inc. showed an increase of +36.6% in Operating Income compared to the prior fiscal year.
- SI-BONE, Inc. reported Gross Profit of $159.88 million for fiscal year 2025.
- SI-BONE, Inc. showed an increase of +21.0% in Gross Profit compared to the prior fiscal year.
- SI-BONE, Inc. reported Shares Outstanding of 43.65 million shares for fiscal year 2025.
- SI-BONE, Inc. showed an increase of +3.7% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: